You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Exelon

Showing 1 - 25 of 53
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bioequivalence Trial in Erfurt (Rivastigmine twice-weekly 9,5 mg/24 h, Exelon® 9.5 mg/24 h)

Active, not recruiting
  • Bioequivalence
  • Rivastigmine twice-weekly 9,5 mg/24 h
  • Exelon® 9.5 mg/24 h
  • Erfurt, Thuringia, Germany
    SocraTec R&D GmbH, Clinical Pharmacology Unit
May 22, 2023

Bioequivalence Trial in Erfurt (RID-TDS 13.3 mg/24 h, Exelon® 13.3 mg/24 h)

Recruiting
  • Bioequivalence
  • RID-TDS 13.3 mg/24 h
  • Exelon® 13.3 mg/24 h
  • Erfurt, Thüringen, Germany
    SocraTec R&D GmbH, Clinical Pharmacology Unit
May 2, 2023

Parkinson Disease, Parkinson Disease Dementia Trial in Baltimore (Rivastigmine transdermal patch)

Completed
  • Parkinson Disease
  • Parkinson Disease Dementia
  • Rivastigmine transdermal patch
  • Baltimore, Maryland
    University of Maryland School of Medicine, Dept. of Neurology
Jan 25, 2022

Alzheimer, Healthy Aging Trial in New Brunswick, North Brunswick (BrightGo cognitive training, Standard of Care medication for

Recruiting
  • Alzheimer Disease
  • Healthy Aging
  • BrightGo cognitive training
  • Standard of Care medication for early Alzheimer's Disease
  • New Brunswick, New Jersey
  • +1 more
Apr 26, 2022

Alzheimer's Disease Trial in India (Rivastigmine)

Completed
  • Alzheimer's Disease
  • Bangalore, Karnataka, India
  • +9 more
Jan 24, 2023

Delirium Trial in Cairo (Rivastigmine Transdermal System [Exelon], Melatonin)

Completed
  • Delirium
  • Rivastigmine Transdermal System [Exelon]
  • Melatonin
  • Cairo, Abassia, Egypt
    Ain Shams University
Jul 8, 2020

Alzheimer, CVA (Cerebrovascular Accident) Trial in Singapore (Rivastigmine)

Completed
  • Alzheimer Disease
  • CVA (Cerebrovascular Accident)
  • Singapore, Singapore
    National Neuroscience Institute
Mar 3, 2021

Parkinson's Disease Trial in Portland (Strattera, Exelon, Placebo)

Completed
Has Results
  • Parkinson's Disease
  • Portland, Oregon
    Oregon Health & Science University
Jun 17, 2020

Bioequivalence Trial in Erfurt (RID-TDS 9.5 mg/24 h, Exelon® 9.5 mg/24 h)

Completed
  • Bioequivalence
  • RID-TDS 9.5 mg/24 h
  • Exelon® 9.5 mg/24 h
  • Erfurt, Thüringen, Germany
    SocraTec R&D GmbH, Clinical Pharmacology Unit
Sep 18, 2019

Dementia, Cognitive Impairment, Mild Cognitive Impairment Trial in Bronx (5-Cog, Health Literacy & Grip Assessment)

Active, not recruiting
  • Dementia
  • +3 more
  • 5-Cog
  • Health Literacy & Grip Assessment
  • Bronx, New York
    Albert Einstein College of Medicine
Dec 21, 2022

Alzheimer, Healthy Aging Trial in North Brunswick (Usability evaluation of BrightGo computerized device for cognitive therapy of

Completed
  • Alzheimer Disease
  • Healthy Aging
  • Usability evaluation of BrightGo computerized device for cognitive therapy of individuals with early Alzheimer's Disease
  • North Brunswick, New Jersey
    Bright Cloud Int'l Corp
Apr 26, 2022

Bioequivalence Trial in Erfurt (RIV-TDS 13.3 mg/24 h, Exelon® 13.3 mg/24 hours transdermal patch)

Completed
  • Bioequivalence
  • RIV-TDS 13.3 mg/24 h
  • Exelon® 13.3 mg/24 hours transdermal patch
  • Erfurt, Thüringen, Germany
    SocraTec R&D GmbH, Clinical Pharmacology Unit
Aug 20, 2018

Alzheimer's Disease Trial in Zapopan, La Plazuela (Erchonia ALS Laser, Placebo Laser)

Completed
  • Alzheimer's Disease
  • Erchonia ALS Laser
  • Placebo Laser
  • Zapopan, Jalisco, Mexico
  • +1 more
May 24, 2021

Delirium Trial in Utrecht (Haloperidol, Methylphenidate, Rivastigmine)

Terminated
  • Delirium
  • Utrecht, Netherlands
    University Medical Center
Mar 19, 2018

Parkinson's Disease, Mild Cognitive Impairment Trial in Philadelphia (Exelon Patch (rivastigmine transdermal system), Placebo

Completed
Has Results
  • Parkinson's Disease
  • Mild Cognitive Impairment
  • Exelon Patch (rivastigmine transdermal system)
  • Placebo Patches
  • Philadelphia, Pennsylvania
    University of Pennsylvania, Ralston House
Feb 22, 2017

Alzheimer's Dementia Trial in Taichung, Taipei (ENA713)

Completed
Has Results
  • Alzheimer's Dementia
  • Taichung, Taiwan ROC, Taiwan
  • +3 more
Apr 16, 2018

Alzheimer's Disease Trial in Korea, Republic of (rivastigmine patch)

Completed
  • Alzheimer's Disease
  • rivastigmine patch
  • Bucheon, Korea, Republic of
  • +15 more
Feb 2, 2018

Mild Cognitive Disorder, Mild Cognitive Impairment Trial in Cleveland (Exelon [rivastigmine] transdermal patch, Placebo

Terminated
Has Results
  • Mild Cognitive Disorder
  • Mild Cognitive Impairment
  • Exelon [rivastigmine] transdermal patch
  • Placebo transdermal patch
  • Cleveland, Ohio
    Cleveland Clinic
Jan 9, 2017

Alzheimer's Disease Trial in Beijing (ENA713)

Completed
Has Results
  • Alzheimer's Disease
  • Beijing, China
    Novartis Investigative Site
Dec 20, 2016

Mild to Moderate Alzheimer's Disease Trial in Japan (Rivastigmine Patch)

Completed
Has Results
  • Mild to Moderate Alzheimer's Disease
  • Rivastigmine Patch
  • Fukuoka city, Fukuoka, Japan
  • +18 more
Aug 5, 2019

Alzheimer's Disease Trial in Israel (Rivastigmine transdermal)

Completed
  • Alzheimer's Disease
  • Rivastigmine transdermal
  • Ashkelon, Israel
  • +4 more
Feb 22, 2017

Cognitive Impairment Trial in Singapore (Exelon (rivastigmine), Placebo)

Completed
  • Cognitive Impairment
  • Exelon (rivastigmine)
  • Placebo
  • Singapore, Singapore
    Singapore General Hospital
Feb 9, 2017

Dementia, Alzheimer's Disease Trial in Fishers, Indianapolis (Donepezil, Galantamine, Rivastigmine)

Terminated
Has Results
  • Dementia
  • Alzheimer's Disease
  • Fishers, Indiana
  • +4 more
Jan 8, 2017

EEG-cholinergic Index and Clinical Response to Treatment With

Unknown status
  • Alzheimer´s Disease
    • (no location specified)
    Aug 16, 2018

    Autonomic Failure, Orthostatic Hypotension Trial in Nashville (drug, other, dietary supplement, device)

    Completed
    • Autonomic Failure
    • Orthostatic Hypotension
    • Nashville, Tennessee
      Vanderbilt University
    Jan 16, 2017